Skip to main content
Poly Medicure Ltd logo

Poly Medicure Ltd — Investor Relations & Filings

Ticker · POLYMED ISIN · INE205C01021 LEI · 335800XM9YRKFWFVXO61 BSE.NS Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2019-05-10 Regulatory Filings
Country IN India
Listing BSE.NS POLYMED

About Poly Medicure Ltd

https://www.polymedicure.com

Poly Medicure Ltd, known as Polymed, is a global medical device company specializing in the design, development, and manufacture of high-quality medical consumables and equipment. The company offers a comprehensive portfolio of over 160 products across various clinical segments, including infusion therapy, oncology, anesthesia, urology, gastroenterology, blood management, and dialysis. Key offerings include IV cannulas, central venous catheters, blood collection systems, and respiratory care devices. With a strong emphasis on research and development, the company operates multiple state-of-the-art manufacturing facilities and maintains international quality certifications. Polymed serves a diverse global market, providing cost-effective and innovative healthcare solutions to hospitals and medical professionals worldwide.

Recent filings

Filing Released Lang Actions
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today ....
Regulatory Filings
2019-05-10 English
Dividend
Regulatory Filings Classification · 100% confidence The document text contains only repeated phrases 'Scanned by CamScanner' and an omitted picture placeholder, with no substantive content, financial data, or report information. The document length is very short (247 characters) and does not contain any report or announcement details. Therefore, it does not fit any specific report category and should be classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without meaningful content.
2019-05-10 English
Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2019, inter alia, to consider the following:1. To consider and ....
Regulatory Filings
2019-05-02 English
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) ....
Regulatory Filings
2019-05-02 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled for May 10, 2019, where the Board will consider and approve the Audited Financial Results for the fiscal year ended March 31, 2019, and also consider dividend recommendations. The document is a formal intimation to stock exchanges about the upcoming Board Meeting agenda. It does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing about the meeting and its agenda, which fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance document. It is not the Annual Report (10-K), nor the Earnings Release (ER), nor a Management Report (MDA). It is also not a Report Publication Announcement (RPA) because it does not announce the publication of a report but rather the meeting to approve such reports.
2019-05-02 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-29 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.